What Happened?
San Diego, CA-based Aspen-Neuroscience Appointed Howard Federoff as Chief Executive Officer
About the Company
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson`s disease (PD) and extending across the brain and affected organs.
About the Person
Howard Federoff is Chief Executive Officer at Aspen Neuroscience. Previously, Howard held various senior HR leadership roles in the industry.
Info Source
News
Short Profile